Basel Medical Group Ltd BMGL

3.70 (0.10) (2.63%) as of 25 Sep
Market cap
$6.0M
P/E
—
Jun '24 Jun '25
P/FCF ratio
0.00 0.00
P/Operating CF
0.00 0.00
P/B ratio
0.00 0.00
Price to Tangible BV
0.00 0.00
EV/Sales
0.00 0.00
EV/EBITDA
0.00 0.00
EV/Operating CF
0.00 0.00
EV/FCF
0.00 0.00
Quick Ratio
2.03 1.19
Current Ratio
2.26 1.23
Net Debt/EBITDA
0.90 (0.42)
Debt/Assets
26.30% 20.29%
Debt/Equity
0.57 0.70
Asset Turnover
0.00 0.70
Operating CF/Net income
1.21 0.36
Capex/Depreciation
(0.26) (0.51)
Interest Coverage
0.00 0.00
ROE
0.00% (202.11%)
ROA
0.00% (75.17%)
ROIC
16.29% (13.62%)
Return on Tangible Assets
22.92% (446.95%)
Average Days of Receivables
456.20 313.78
Research and Development Expense of Revenue
0.00% 0.00%
Selling, General and Administrative Expense of Revenue
36.21% 56.52%
Intangible Assets out of Total Assets
0.00 0.00
Share Based Compensation of Revenue
0.00% 0.00%
Graham Net Nets
0.00 0.00
Graham Number
0.00 0.00
Free Cash Flow Yield
0.00% 0.00%
Revenue per Share
5.48 5.69
Operating CF per Share
1.37 (2.18)
Capex per Share
0.00 (0.03)
Free Cash Flow per Share
1.36 (2.21)
Cash per Share
1.06 1.50
Shareholders Equity per Share
4.12 2.44
Interest Debt per Share
0.00 0.00
Book value per Share
4.12 2.44
Free Cash Flow
1.85 (3.46)
Working Capital
6.65 1.91
Capital Expenditures
(0.01) (0.04)
Net Current Asset Value
5.48 0.89
EV/EBIT
0.00 0.00
Capex to Sales
0.00 0.00
Net Profit Margin
20.62% (106.78%)
Other line items
Depreciation/Fixed assets
0.87 0.39
Cash ROIC
17.93% (41.03%)
Accounts Receivable Turnover
0.00 1.05
Accounts Payable Turnover
0.00 0.54
Inventory Turnover
0.00 11.38
Average Days of Payables
418.22 998.82
Days of Inventory on Hand
11.71 54.38
Average Receivables
— 8.46
Average Payables
— 3.67
Average Inventory
— 0.17
Average Assets
— 12.64
Average Common Equity
— 4.70

Fold the line items

Columns are period end dates